相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
Dalit Barkan et al.
EUROPEAN JOURNAL OF CANCER (2010)
Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells
Pay-Chin Leow et al.
INVESTIGATIONAL NEW DRUGS (2010)
Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma
Yongping Cai et al.
JOURNAL OF PATHOLOGY (2010)
Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
Elyssa M. Rubin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The Role of Interferons in the Treatment of Osteosarcoma
Jeremy Whelan et al.
PEDIATRIC BLOOD & CANCER (2010)
High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005
Antonio Briccoli et al.
SURGICAL ONCOLOGY-OXFORD (2010)
Anti-angiogenic factor endostatin in osteosarcoma
Hyun-Soo Kim et al.
APMIS (2009)
Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45 alpha expression
Cao Yang et al.
APOPTOSIS (2009)
Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
M. Tanaka et al.
BRITISH JOURNAL OF CANCER (2009)
Correlation Between Clinical Outcome and Growth Factor Pathway Expression in Osteogenic Sarcoma
Ayesha Abdeen et al.
CANCER (2009)
Addition of Muramyl Tripeptide to Chemotherapy for Patients With Newly Diagnosed Metastatic Osteosarcoma
Alexander J. Chou et al.
CANCER (2009)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
Nava Almog et al.
CANCER RESEARCH (2009)
Silencing of calpain expression reduces the metastatic potential of human osteosarcoma cells
De-Gang Fan et al.
CELL BIOLOGY INTERNATIONAL (2009)
Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
Pooja Hingorani et al.
CLINICAL CANCER RESEARCH (2009)
Targeted Therapies in Bone Sarcomas
K. Scotlandi et al.
CURRENT CANCER DRUG TARGETS (2009)
Strategies for the targeted delivery of therapeutics for osteosarcoma
Dennis P. M. Hughes
EXPERT OPINION ON DRUG DELIVERY (2009)
Notch signaling contributes to the pathogenesis of human osteosarcomas
Feyza Engin et al.
HUMAN MOLECULAR GENETICS (2009)
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Emmanuelle Pradelli et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
What's New in Musculoskeletal Oncology
Valerae O. Lewis
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
Stromal Cell-Derived Factor-1/CXCR4 Enhanced Motility of Human Osteosarcoma Cells Involves MEK1/2, ERK and NF-κB-Dependent Pathways
Chun-Yin Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
Maya Kansara et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Osteosarcoma
Patrick J. Messerschmitt et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2009)
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
Ymera Pignochino et al.
MOLECULAR CANCER (2009)
Src kinases as therapeutic targets for cancer
Lori C. Kim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC
L. Ren et al.
ONCOGENE (2009)
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin
X. Wan et al.
ONCOGENE (2009)
Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy
Elena Favaro et al.
APMIS (2008)
Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis
Filontena de Nigris et al.
CANCER RESEARCH (2008)
Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma
Michela Pasello et al.
CANCER RESEARCH (2008)
被撤回的出版物: Critical role of Notch signaling in osteosarcoma invasion and metastasis (Retracted article. See vol. 19, pg. 5256, 2013)
Pingyu Zhang et al.
CLINICAL CANCER RESEARCH (2008)
Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model
Yi Guo et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
Bone Tumors in Adolescents and Young Adults
Stefan S. Bielack et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2008)
Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosareoma)
Pete Anderson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness
I-Ching Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases
Nidra I. Rodriguez et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
High Grade Osteosarcoma of the Extremities With Lung Metastases at Presentation: Treatment With Neoadjuvant Chemotherapy and Simultaneous Resection of Primary and Metastatic Lesions
Gaetano Bacci et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the Pediatric Preclinical Testing Program
E. Anders Kolb et al.
PEDIATRIC BLOOD & CANCER (2008)
Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in pediatric solid tumors
Joerg Fuchs et al.
SURGICAL ONCOLOGY-OXFORD (2008)
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Su Young Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Interferon-α enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis
Xiang-wei Yuan et al.
ACTA PHARMACOLOGICA SINICA (2007)
Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin
Mitsunori Kaya et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2007)
Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine
Nancy Gordon et al.
CLINICAL CANCER RESEARCH (2007)
Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells
Yi Guo et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2007)
Metastasis: recent discoveries and novel treatment strategies
Suzanne A. Eccles et al.
LANCET (2007)
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
H. Christian Reinhardt et al.
CANCER CELL (2007)
Molecular pathogenesis of osteosarcoma
Maya Kansara et al.
DNA AND CELL BIOLOGY (2007)
Bone marrow cells in the 'pre-metastatic niche': within bone and beyond
Rosandra N. Kaplan et al.
CANCER AND METASTASIS REVIEWS (2006)
Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases
Randi G. Syljuasen et al.
CANCER RESEARCH (2006)
Effect of interleukin-18 on metastasis of mouse osteosarcoma cells
Yoshiteru Nakamura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation
C. Marcela Diaz-Montero et al.
EUROPEAN JOURNAL OF CANCER (2006)
Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcorna lung metastases
XP Duan et al.
CANCER (2006)
Normal cells, but not cancer cells, survive severe Plk1 depletion
XQ Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Clinico-histologic parameters of osteosarcoma patients with late relapse
EI Hauben et al.
EUROPEAN JOURNAL OF CANCER (2006)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
The biology of metastases in pediatric sarcomas
K Krishnan et al.
CANCER JOURNAL (2005)
Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma
C Laverdiere et al.
CLINICAL CANCER RESEARCH (2005)
Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma
BH Hoang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
C Khanna et al.
NATURE MEDICINE (2004)
Increased Fas expression reduces the metastatic potential of human osteosarcoma cells
EA Lafleur et al.
CLINICAL CANCER RESEARCH (2004)
Late relapse of osteosarcoma: Implications for follow-up and screening
SJ Strauss et al.
PEDIATRIC BLOOD & CANCER (2004)
Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants - or both?
RO Hynes
CELL (2003)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo
T Kashima et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: Significant reduction of insulin-like growth factor-1 serum levels
PJ Mansky et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Death and anti-death: Tumour resistance to apoptosis
FH Igney et al.
NATURE REVIEWS CANCER (2002)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Chemokines and the molecular basis of cancer metastasis.
PM Murphy
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
